0649 GMT - Bayer's results should lead to a positive share price response after the company posted better-than-expected earnings and reiterated its outlook, Jefferies analysts say in a note. The German pharmaceutical and agricultural company now forecasts its outlook for the pharma division at the upper end of its guidance range, the analysts say. Its 1Q earnings and sales topped company-compiled and Jefferies' consensus, they say. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
May 13, 2025 02:50 ET (06:50 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.